DrugBank ID: db09061
DrugCentral: cannabidiol
Synonymous :(−)-trans-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol | (−)-trans-cannabidiol | (1’r,2’r)-5’-methyl-4-pentyl-2’-(prop-1-en-2-yl)-1’,2’,3’,4’-tetrahydrobiphenyl-2,6-diol | cannabidiol | cbd | δ1(2)-trans-cannabidiol

Drug Sentece Context

Table 1. Analysis of context sentence of cannabidiol gene in 2 abstracts.

pmid sentence
32519753 We suggest the hypothesis that Cannabidiol (CBD), a non-psychotropic phytocannabinoid, has the potential to limit the severity and progression of the disease for several reasons: 1) High-CBD Cannabis Sativa extracts are able to downregulate the expression of the two key receptors for SARS-CoV2 in several models of human epithelia 2) CBD exerts a wide range of immunomodulatory and anti-inflammatory effects and it can mitigate the uncontrolled cytokine production featuring Acute Lung Injury 3) Being a PPARγ agonist, it can display a direct antiviral activity 4) PPARγ agonists are regulators of fibroblast/myofibroblast activation and can inhibit the development of pulmonary fibrosis, thus ameliorating lung function in recovered patients.
32699671 Many cannabidiol (CBD) retailers make unsupported medical claims about their product.
32804502 This Perspective of the published essential medicinal chemistry of cannabidiol (CBD) provides evidence that the popularization of CBD-fortified or CBD-labeled health products and CBD-associated health claims lacks a rigorous scientific foundation.
32923657 Among all cannabinoids, cannabidiol (CBD) has demonstrated potent anti-inflammatory effects in a variety of pathological conditions.
33001829 There is some scientific evidence that vaping, cannabidiol (CBD - an active ingredient in cannabis from the hemp plant) or other substances, may be associated with more severe manifestations of COVID-19.